oi-Briti Roy Barman
New Delhi, Sep 28: Australian biotech company Ena Respiratory has said a nasal spray that it is developing to improve human immune system to fight common cold and flu significantly reduced coronavirus growth in a recent study on animals.
INNA-051 reduced COVID-19 viral replication by up to 96 per cent in ferrets, the company said.
The study was led by British government agency Public Health England.
The study on ferrets showed the product dubbed INNA-051, which could be used complementary to vaccines, lowered the levels of the virus that causes coronavirus. the company said.
Notably, the company has raised $8.24 million for the development of the spray.
Investors include venture capital firm Brandon Capital Ltd, the Australian federal government,…